| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |